Is Avicanna Inc. (AVCN.TO) a Buy, Sell, or Hold?
TSX : AVCN.TO
Avicanna Inc. — News
$0.125 CAD
$0 (0.0%)
- Volume
- 73K
- Average Volume
- 209.79K
- Market Capitalization
- $15.72M
- P/E Ratio
- -4.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.31
- Year Low
- $0.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.96
| Source | Headline |
|---|---|
|
Avicanna Announces Change in Board of Directors
TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is announces that Eileen McCormack, who was not on the slate of directors for re-election or election as outlined in the circular at the upcoming annual general and special meeting of shareholders scheduled for Thursday May 7, 2026, has tendered her resignation as a member of the board of directors effective Friday May 1, 2026 ahead of the annual general and special meeting of shareholders. globenewswire.com - 2026-05-01 20:46:30 |
